Kidney Cancer
-
VUMC study reveals critical first steps to cancer
A new study by Vanderbilt researchers provides a remarkably detailed view of the earliest events leading to the development of cancer, and of potential new ways to prevent it. Read MoreSep 20, 2023
-
Genetic differences in Wilms tumor
Unique somatic gene mutations may contribute to racial disparities in the incidence of Wilms tumor — the most common childhood kidney cancer. Read MoreApr 6, 2021
-
Study underscores importance of personalized medicine in kidney cancer
A new study sheds light on how molecular subsets within the tumors of kidney cancer patients determine treatment outcomes and underscores the importance of personalized medicine in making therapy decisions. Read MoreNov 10, 2020
-
Grant bolsters kidney cancer immunotherapy research
W. Kimryn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt-Ingram Cancer Center (VICC), has received a grant to research the role of immunosuppression in the tumor microenvironment for kidney cancer. Read MoreMay 10, 2018
-
Kidney cancer patient, survivor event set for Sept. 9
Vanderbilt-Ingram Cancer Center (VICC) will sponsor an educational conference for kidney cancer patients, survivors and family members Saturday, Sept. 9, 8 a.m. – 2 p.m., in the Preston Research Building, Suite 898. Read MoreAug 17, 2017
-
Kidney cancer educational conference at VICC set Sept. 10
Kidney cancer patients, family members, health care providers and members of the public are invited to attend a free educational workshop about the disease to be held at Vanderbilt-Ingram Cancer Center (VICC). Read MoreSep 2, 2016
-
VICC helps launch new alliance for rare kidney cancer
Children, adolescents or young adults, particularly African-Americans, diagnosed with advanced kidney cancer may actually have a rare form of the disease known as renal medullary carcinoma (RMC) that requires a specialized approach and expert intervention. Read MoreAug 18, 2016
-
Study shows statin use improves renal cell cancer survival
A new study led by Vanderbilt University investigators found that patients being treated with statins at the time of surgery for kidney cancer, also known as renal cell carcinoma, had improved overall survival and disease-specific survival. Read MoreApr 16, 2015
-
Exploring Wilms tumor race disparity
Unique molecular "fingerprints" could explain the disparity in Wilms tumor incidence and point to novel, race-specific therapeutic targets. Read MoreMay 29, 2014
-
Wilms’ tumors differ in developing nations
In addition to limited health care resources, biological factors may play a role in the poor survival of children with a common kidney cancer in developing nations. Read MoreApr 13, 2012